Ironwood names Tammi Gaskins CEO effective Jan. 1, 2027

IRWD•2026-11-05

Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins CEO and a director, effective January 1, 2027. Tom McCourt will retire as CEO on the same date.

1. CEO transition

Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins CEO and a director, effective January 1, 2027. Tom McCourt will retire as CEO that day.

Sources

Ironwood names Tammi Gaskins CEO effective Jan. 1, 2027

Sec

Ironwood names Tammi Gaskins CEO effective Jan. 1, 2027

1. CEO transition

Related News

CRH director Siobhan Talbot reports acquisition of $189,260 in common shares

Cronos Group Q3 net income USD 17.8 million

Netscout Systems Q2 adjusted net income $52.8 million

Sources

Ironwood names Tammi Gaskins CEO effective Jan. 1, 2027

Agilon health to host virtual investor event on clinical strategy and technology platform

Priority Technology Q3 revenue $268.623 million vs. IBES estimate $259.2 million